Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: Role of polymorphisms of genes involved in glucocorticoid response

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pediatric Blood & Cancer

• Publication date

  2009-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.22163PMID 19621425
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction

  2009cited by this paper
• Pharmacogenetics in acute lymphoblastic leukemia.

  2009cited by this paper
• Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemia.

  2008cited by this paper
• Acute lymphoblastic leukaemia.

  2008cited by this paper
• The epidemiology of glucocorticoid-associated adverse events

  2008cited by this paper
• Impact of genetic polymorphisms of transporters on the pharmacokinetic, pharmacodynamic and toxicological properties of anionic drugs.

  2008cited by this paper
• Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

  2008cited by this paper
• MDR-1 gene polymorphisms and clinical course of steroid-responsive nephrotic syndrome in children

  2007cited by this paper
• Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity

  2006cited by this paper
• Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia

  2006cited by this paper
• Glucocorticoid receptor polymorphisms and post-traumatic stress disorder.

  2005cited by this paper
• GSTP1 and MDR1 Genotypes and Central Nervous System Relapse in Childhood Acute Lymphoblastic Leukemia

  2005cited by this paper
• The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia

  2004cited by this paper
• Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia

  2004cited by this paper
• Overview of the Actions of Glucocorticoids on the Immune Response: A Good Model to Characterize New Pathways of Immunosuppression for New Treatment Strategies

  2004cited by this paper
• Pediatr Blood Cancer

  2004cited by this paper
• The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults.

  2004cited by this paper
• Pharmacogenetics of acute lymphoblastic leukemia

  2004cited by this paper
• Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition.

  2004cited by this paper
• Structural Determinants of P-Glycoprotein-Mediated Transport of Glucocorticoids

  2003cited by this paper
• Patient stratification based on prednisolone-vincristine-asparaginase resistance profiles in children with acute lymphoblastic leukemia.

  2003cited by this paper
• The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone.

  2002cited by this paper
• Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes

  2002cited by this paper
• Glutathione-S-transferase family of enzymes.

  2001cited by this paper
• Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects

  2001cited by this paper
• Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene.

  2001cited by this paper
• Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.

  2001cited by this paper
• Clinical Outcome of Patients with Childhood Acute Lymphoblastic Leukaemia and an Initial Leukaemic Blood Blast Count of Less than 1000 per Microliter

  2001cited by this paper
• Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.

  2000cited by this paper
• lymphoblastic leukemia : a case-control study ) and risk of relapse in childhood B-cell precursor acute GSTP 1 , GSTT 1 , GSTM 1 Polymorphisms within glutathione S-transferase genes

  2000cited by this paper
• Glutathione S-transferase polymorphisms and colorectal cancer: a HuGE review.

  2000cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

  2000cited by this paper
• Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia

  2000cited by this paper
• Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

  2000influential reference
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995

  2000cited by this paper
• High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy.

  2000cited by this paper
• Interleukin-10 and Gp130 cytokines in human multiple myeloma.

  1999cited by this paper
• Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor.

  1999cited by this paper
• A review of the association between interleukin-10 and human B-cell malignancies

  1998cited by this paper
• Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice.

  1998cited by this paper
• Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.

  1998cited by this paper
• Modulation of antioxidant defenses during apoptosis.

  1997cited by this paper
• Chemosensitizing steroids: glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function.

  1997cited by this paper
• Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance

  1997cited by this paper
• Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer.

  1997cited by this paper
• Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia.

  1997cited by this paper
• In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia.

  1997cited by this paper
• Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

  1993cited by this paper
• An association between a Bc1I restriction fragment length polymorphism of the glucocorticoid receptor locus and hyperinsulinaemia in obese women.

  1992cited by this paper
• Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.

  1992cited by this paper
• A subclass of glutathione S-transferases as intracellular high-capacity and high-affinity steroid-binding proteins.

  1986cited by this paper
• Identification of Yb-glutathione-S-transferase as a major rat liver protein labeled with dexamethasone 21-methanesulfonate.

  1985cited by this paper
• Preferential binding of steroids by anionic forms of rat glutathione S-transferase.

  1984cited by this paper

• The role of pharmacogenetics in the therapy regimen of acute lymphoblastic leukemia in children: recent discoveries and future perspectives

  2026cites this paper
• Association of GST polymorphism with adverse drug reactions: an analysis across multiple drug categories

  2024influential citation
• Genetic basis of clinical variants of chemotherapy toxicity in children with acute lymphoblastic leukemia (literature review)

  2022cites this paper
• Enzyme Vs Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia

  2021cites this paper
• Risk factors for steroid‐induced adverse psychological reactions and sleep problems in pediatric acute lymphoblastic leukemia: A systematic review

  2021influential citation
• Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia

  2020cites this paper
• Inherited genetic variants associated with glucocorticoid sensitivity in leukaemia cells

  2020cites this paper
• The influence of polymorphisms in the drug transporter, ABCB1 on the toxicity of glucocorticoids in Saudi children with acute lymphoblastic leukaemia

  2019cites this paper
• NR3C1, ABCB1, TNF and CYP2C19 polymorphisms association with the response to the treatment of erythema nodosum leprosum.

  2019cites this paper
• The Effect of Combination of Steroid and L-Asparaginase on Hyperglycemia in Children with Acute Lymphoblastic Leukemia (ALL)

  2019cites this paper
• Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment

  2019cites this paper
• Splicing variant profiles and single nucleotide polymorphisms of the glucocorticoid receptor gene in relation to glucocorticoid sensitivity of B‐cell precursor acute lymphoblastic leukaemia

  2018cites this paper
• Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia

  2018cites this paper
• DNA Methylation Modifications Associated with Glucocorticoid Sensitivity and Clinical Subtypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  2018cites this paper
• NR3C1 (nuclear receptor subfamily 3, group C, member 1/glucocorticoid receptor)

  2017cites this paper
• Association of ABCB1 C3435T polymorphism with the susceptibility to osteonecrosis of the femoral head

  2017cites this paper
• Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  2017cites this paper
• Association Between N363S and BclI Polymorphisms of the Glucocorticoid Receptor Gene (NR3C1) and Glucocorticoid Side Effects During Childhood Acute Lymphoblastic Leukemia Treatment

  2017influential citation
• Genetic variation in the glucocorticoid pathway involved in interindividual differences in the glucocorticoid treatment.

  2017cites this paper
• Medical Supportive Care for Treatment-Related Toxicity in Childhood ALL

  2017cites this paper
• Antileukemia Effect of Ciclopirox Olamine Is Mediated by Downregulation of Intracellular Ferritin and Inhibition β-Catenin-c-Myc Signaling Pathway in Glucocorticoid Resistant T-ALL Cell Lines

  2016cites this paper
• Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6‐Mercaptopurine in Children With Acute Lymphoblastic Leukemia

  2016cites this paper
• Pharmacogenetics and induction/consolidation therapy toxicities in acute lymphoblastic leukemia patients treated with AIEOP-BFM ALL 2000 protocol

  2015cites this paper
• Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome.

  2015cites this paper
• Pharmacogenetics predictive of response and toxicity in acute lymphoblastic leukemia therapy.

  2015cites this paper
• IL-10 gene polymorphism and influence of chemotherapy on cytokine plasma levels in childhood acute lymphoblastic leukemia patients: IL-10 polymorphism and plasma levels in leukemia patients.

  2015cites this paper
• Host Genome Variation and Toxicity in Childhood Acute Lymphoblastic Leukaemia

  2014cites this paper
• Pharmacogenetics of childhood acute lymphoblastic leukemia.

  2014cites this paper
• Pharmacogenetic considerations for acute lymphoblastic leukemia therapies

  2014cites this paper
• Multilocus Genotypes of Relevance for Drug Metabolizing Enzymes and Therapy with Thiopurines in Patients with Acute Lymphoblastic Leukemia

  2013cites this paper
• New genetic markers for treatment personalization in pediatric Acute Lymphoblastic Leukemia

  2013cites this paper
• A pilot pharmacogenomics study examining the influence of cytotoxic and metabolising genetic polymorphisms on chemotherapy toxicity and outcome in osteosarcoma

  2013cites this paper
• Curing acute lymphoblastic leukemia and avoiding osteonecrosis: Can't we have it all?

  2013cites this paper
• Gene Dose Effects of GSTM1, GSTT1 and GSTP1 Polymorphisms on Outcome in Childhood Acute Lymphoblastic Leukemia

  2012cites this paper
• Molecular Techniques Used in the Evaluation of Pediatric Acute Leukemia

  2012cites this paper
• Dexamethasone versus prednisone for induction therapy in childhood acute lymphoblastic leukemia: a systematic review and meta-analysis

  2011cites this paper
• Glutathione S-Transferases in Pediatric Cancer

  2011cites this paper
• Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control study.

  2011cites this paper
• Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.

  2011cites this paper
• Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group

  2010cites this paper
• Rapamycin sensitizes T-ALL cells to dexamethasone-induced apoptosis

  2010cites this paper
• Pharmacogenomics of pediatric acute lymphoblastic leukemia

  2010cites this paper
• Recent Publications on Medications and Pharmacy

  2010cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2010cites this paper
• Recent Publications on Medications and Pharmacy

  2009cites this paper